Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 15725804)

1.

Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: importance of tumor necrosis.

Pu RT, Schott AF, Sturtz DE, Griffith KA, Kleer CG.

Am J Surg Pathol. 2005 Mar;29(3):354-8.

PMID:
15725804
2.

Little things make big things happen: angiolymphatic invasion and tumor necrosis prognosticate the outcome of locally advanced non-small cell lung cancer treated with a prior induction therapy.

Marquez-Medina D, Martin-Marco A, Caldero SG, Montero-Fernandez A.

Am J Clin Pathol. 2015 Jun;143(6):889-94. doi: 10.1309/AJCPYQ8V3BXSWRWG.

PMID:
25972332
3.

Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches.

Pinder SE, Rakha EA, Purdie CA, Bartlett JM, Francis A, Stein RC, Thompson AM, Shaaban AM; the Translational Subgroup of the NCRI Breast Clinical Studies Group.

Histopathology. 2015 Jan 14. doi: 10.1111/his.12649. [Epub ahead of print]

PMID:
25585651
4.

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study.

Balmativola D, Marchiò C, Maule M, Chiusa L, Annaratone L, Maletta F, Montemurro F, Kulka J, Figueiredo P, Varga Z, Liepniece-Karele I, Cserni G, Arkoumani E, Amendoeira I, Callagy G, Reiner-Concin A, Cordoba A, Bianchi S, Decker T, Gläser D, Focke C, van Diest P, Grabau D, Lips E, Wesseling J, Arisio R, Medico E, Wells C, Sapino A.

Breast Cancer Res Treat. 2014 Dec;148(3):511-23. doi: 10.1007/s10549-014-3192-3. Epub 2014 Nov 14.

5.

A case of complicated survivorship care.

Rosiak J, Humphreys C.

J Adv Pract Oncol. 2014 Jan;5(1):64-8. Review.

6.

The promise of axillary imaging in individualized surgical management of breast cancer patients: another step forward.

Hieken TJ.

Ann Surg Oncol. 2014 Oct;21(11):3369-71. doi: 10.1245/s10434-014-3853-9. Epub 2014 Jun 17. No abstract available.

PMID:
24934586
7.

Different methods of pretreatment Ki-67 labeling index evaluation in core biopsies of breast cancer patients treated with neoadjuvant chemotherapy and their relation to response to therapy.

Vörös A, Csörgő E, Kővári B, Lázár P, Kelemen G, Rusz O, Nyári T, Cserni G.

Pathol Oncol Res. 2015 Jan;21(1):147-55. doi: 10.1007/s12253-014-9800-z. Epub 2014 May 25.

PMID:
24859973
8.

Thalidomide combined with neoadjuvant chemotherapy in angiosarcoma of the breast with complete pathologic response: case report and review of literature.

Alvarado-Miranda A, Bacon-Fonseca L, Ulises Lara-Medina F, Maldonado-Martínez H, Arce-Salinas C.

Breast Care (Basel). 2013 Mar;8(1):74-6. doi: 10.1159/000346822.

9.
10.

Association of estrogen receptor, progesterone receptor and HER2 following neoadjuvant systemic treatment in breast cancer patients undergoing surgery.

Tsai YM, Hsu HM, Chen CJ, Hsu KF, Fan HL, Chang H, Chan DC, Yu JC.

Ir J Med Sci. 2014 Mar;183(1):71-5. doi: 10.1007/s11845-013-0975-1. Epub 2013 Jun 12.

PMID:
23757214
11.

The impact of tumor size in breast needle biopsy material on final pathologic size and tumor stage: a detailed analysis of 222 consecutive cases.

Edwards HD, Oakley F, Koyama T, Hameed O.

Am J Surg Pathol. 2013 May;37(5):739-44. doi: 10.1097/PAS.0b013e31828c63d0.

PMID:
23552386
12.

Reliability of receptor assessment on core needle biopsy in breast cancer patients.

Seferina SC, Nap M, van den Berkmortel F, Wals J, Voogd AC, Tjan-Heijnen VC.

Tumour Biol. 2013 Apr;34(2):987-94. doi: 10.1007/s13277-012-0635-5. Epub 2012 Dec 27.

PMID:
23269610
13.

Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens.

Provenzano E, Brown JP, Pinder SE.

Clin Oncol (R Coll Radiol). 2013 Feb;25(2):80-92. doi: 10.1016/j.clon.2012.10.008. Epub 2012 Nov 27. Review.

PMID:
23199579
14.

Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.

Duman BB, Afşar ÇU, Günaldi M, Sahin B, Kara IO, Erkisi M, Erçolak V.

Asian Pac J Cancer Prev. 2012;13(8):4119-23.

15.

Common protein biomarkers assessed by reverse phase protein arrays show considerable intratumoral heterogeneity in breast cancer tissues.

Malinowsky K, Raychaudhuri M, Buchner T, Thulke S, Wolff C, Höfler H, Becker KF, Avril S.

PLoS One. 2012;7(7):e40285. doi: 10.1371/journal.pone.0040285. Epub 2012 Jul 5.

16.

Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.

Gatek J, Vrana D, Hnatek L, Bakala J, Dudesek B, Duben J, Musil T.

J BUON. 2012 Apr-Jun;17(2):265-70.

PMID:
22740204
17.

Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.

Yang C, Liu F, Li S, Li W, Zhai L, Ren M, Li Y, Lang R, Fan Y, Zhang X, Fu L.

Int J Surg Pathol. 2012 Dec;20(6):546-54. doi: 10.1177/1066896912451323. Epub 2012 Jun 25.

PMID:
22736300
18.

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, Gerber B, Eiermann W, Hilfrich J, Huober J, Jackisch C, Kaufmann M, Konecny GE, Denkert C, Nekljudova V, Mehta K, Loibl S.

J Clin Oncol. 2012 May 20;30(15):1796-804. doi: 10.1200/JCO.2011.38.8595. Epub 2012 Apr 16.

19.

Factors influencing axillary lymph node metastasis in invasive breast cancer.

Li L, Chen LZ.

Asian Pac J Cancer Prev. 2012;13(1):251-4.

20.

The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer.

Woolston CM, Zhang L, Storr SJ, Al-Attar A, Shehata M, Ellis IO, Chan SY, Martin SG.

Mod Pathol. 2012 Aug;25(8):1106-16. doi: 10.1038/modpathol.2012.60. Epub 2012 Apr 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk